Proposed Data Collection Submitted for Public Comment and Recommendations, 71280-71281 [2024-19613]
Download as PDF
71280
Federal Register / Vol. 89, No. 170 / Tuesday, September 3, 2024 / Notices
cases. These cases represent the number
of TB cases that would have been
missed under the old screening
program.
Æ Compare TB Indicator incidence
rates to WHO country-specific TB
incidence rates for internal quality
assessment purposes only.
Æ Detect and resolve problems at
panel sites demonstrating lower than
expected TB detection rates.
Data will primarily be used internally
to monitor program impact, but may
also be shared with state and local
health authorities involved in TB
control. Information dissemination may
include abstract submission to scientific
conferences, including the Union World
Conference on Lung Health, the
National TB Controllers Association and
the Panel Physician Training Summits.
Information will be collected from
each Panel Physician site using a web
form created with REDCap on an annual
basis. The TB-related information that is
sent to CDC is aggregate in nature, and
no personal identifying information (PII)
from any applicant for U.S. immigration
is included. Information to be collected
using the spreadsheet includes:
• number of applicants screened,
• age categories of applicants,
• number of abnormal chest x-rays,
• acid fast bacilli (AFB) smear results,
• mycobacterium tuberculosis (MTB)
cultures,
• drug susceptibility test (DST)
results, and
• TB treatment disposition.
The changes in this Revision include
the additional collection of molecular
testing data. CDC requests OMB
approval for an estimated 999 annual
burden hours. There is no cost to
respondents other than their time to
participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
International Panel Physicans ........................
TB Indicators REDCap Web Form ................
333
1
3
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–19612 Filed 8–30–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–23FN; Docket No. CDC–2024–
0061]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled, Menthol-Flavored Tobacco
Products Policy Evaluation. The
proposed activity aims to collect data on
menthol-flavored tobacco product use,
any tobacco use, quit rates, and product
tkelley on LAP7H3WLY3PROD with NOTICES2
SUMMARY:
VerDate Sep<11>2014
22:46 Aug 30, 2024
Jkt 262001
switching behaviors among adults 18
years of age and older.
DATES: CDC must receive written
comments on or before November 4,
2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0061 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
U:\REGISTER\03SEN1.SGM
03SEN1
71281
Federal Register / Vol. 89, No. 170 / Tuesday, September 3, 2024 / Notices
Proposed Project
Menthol-Flavored Tobacco Products
Policy Evaluation—New—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is submitting this new
information collection request (ICR) for
an evaluation of local policies
restricting the sale of menthol and other
flavored tobacco products on outcomes
such as menthol-flavored tobacco
product use, any tobacco use, quit rates,
and product switching behaviors. The
evaluation will also study the impact
community education efforts associated
with the flavored tobacco product sales
restriction policies have on individuals’
research on local tobacco policies
indicates they are effective at limiting
the availability of policy-restricted
products, there is a lack of information
on the policies’ potential impact on
tobacco use behaviors (e.g., product
switching behavior, online purchasing).
There have been no other evaluation
data collection efforts conducted on this
topic to date, nor does the information
to be collected exist in any existing
centralized data source. Each data
collection tool submitted through this
package has a distinct purpose with no
overlap across other tools or data
collection efforts.
OMB approval is requested for three
years. The total annualized burden
hours is 3047 hours. There are no costs
to respondents other than their time to
participate.
awareness of the policies and
perceptions about the harms of tobacco
use. This evaluation seeks to explore the
effects of the policies on racial and
ethnic groups (American Indian or
Alaska Native, Asian, Black or African
American, Native Hawaiian or Other
Pacific Islander, and Hispanic or Latino
populations), and lesbian, gay, bisexual,
transgender, queer, and/or questioning
(LGBTQ+) communities specifically, as
these populations are known to use
menthol-flavored tobacco products at a
higher prevalence than other
populations and may therefore be most
affected by policies addressing mentholflavored tobacco use. Understanding
how the aforementioned policies impact
menthol-flavored tobacco product use
may help to inform public health
activities and decisions regarding
tobacco control. Although some
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hr)
Total
burden
(in hr)
Form name
General population ............................
Individuals in racial and ethnic
groups.
LGBTQ+ individuals ..........................
General population ............................
Individuals in racial and ethnic
groups.
LGBTQ+ individuals ..........................
General population ............................
Survey Screener Questionnaire .......
Survey Screener Questionnaire .......
9875
1500
1
1
2/60
2/60
329
50
Survey Screener Questionnaire .......
Community Web-Panel Survey ........
Community Web-Panel Survey ........
1,125
4050
600
1
1
1
2/60
30/60
30/60
38
2025
300
Community Web-Panel Survey ........
Focus Group Screener Questionnaire.
Focus Group Screener Questionnaire.
Focus Group Screener Questionnaire.
Community Focus Group .................
Community Focus Group .................
450
34
1
1
30/60
3/60
225
2
33
1
3/60
2
33
1
3/60
2
25
25
1
1
60/60
60/60
25
25
Community Focus Group .................
..........................................................
25
........................
1
........................
60/60
........................
25
3047
Individuals in racial and ethnic
groups.
LGBTQ+ individuals ..........................
General population ............................
Individuals in racial and ethnic
groups.
LGBTQ+ individuals ..........................
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–19613 Filed 8–30–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–1050; Docket No. CDC–2024–
0062]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
tkelley on LAP7H3WLY3PROD with NOTICES2
Number of
responses per
respondent
Type of respondent
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
SUMMARY:
VerDate Sep<11>2014
22:46 Aug 30, 2024
Jkt 262001
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled CDC/ATSDR
Generic Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery. The information collection
activities provide a means to garner
qualitative customer and stakeholder
feedback in an efficient, timely manner,
in accordance with the Federal
Government’s commitment to
improving service delivery.
U:\REGISTER\03SEN1.SGM
03SEN1
Agencies
[Federal Register Volume 89, Number 170 (Tuesday, September 3, 2024)]
[Notices]
[Pages 71280-71281]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-19613]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-24-23FN; Docket No. CDC-2024-0061]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled, Menthol-Flavored Tobacco
Products Policy Evaluation. The proposed activity aims to collect data
on menthol-flavored tobacco product use, any tobacco use, quit rates,
and product switching behaviors among adults 18 years of age and older.
DATES: CDC must receive written comments on or before November 4, 2024.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0061 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
[[Page 71281]]
Proposed Project
Menthol-Flavored Tobacco Products Policy Evaluation--New--National
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) is submitting
this new information collection request (ICR) for an evaluation of
local policies restricting the sale of menthol and other flavored
tobacco products on outcomes such as menthol-flavored tobacco product
use, any tobacco use, quit rates, and product switching behaviors. The
evaluation will also study the impact community education efforts
associated with the flavored tobacco product sales restriction policies
have on individuals' awareness of the policies and perceptions about
the harms of tobacco use. This evaluation seeks to explore the effects
of the policies on racial and ethnic groups (American Indian or Alaska
Native, Asian, Black or African American, Native Hawaiian or Other
Pacific Islander, and Hispanic or Latino populations), and lesbian,
gay, bisexual, transgender, queer, and/or questioning (LGBTQ+)
communities specifically, as these populations are known to use
menthol-flavored tobacco products at a higher prevalence than other
populations and may therefore be most affected by policies addressing
menthol-flavored tobacco use. Understanding how the aforementioned
policies impact menthol-flavored tobacco product use may help to inform
public health activities and decisions regarding tobacco control.
Although some research on local tobacco policies indicates they are
effective at limiting the availability of policy-restricted products,
there is a lack of information on the policies' potential impact on
tobacco use behaviors (e.g., product switching behavior, online
purchasing). There have been no other evaluation data collection
efforts conducted on this topic to date, nor does the information to be
collected exist in any existing centralized data source. Each data
collection tool submitted through this package has a distinct purpose
with no overlap across other tools or data collection efforts.
OMB approval is requested for three years. The total annualized
burden hours is 3047 hours. There are no costs to respondents other
than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hr) (in hr)
----------------------------------------------------------------------------------------------------------------
General population............ Survey Screener 9875 1 2/60 329
Questionnaire.
Individuals in racial and Survey Screener 1500 1 2/60 50
ethnic groups. Questionnaire.
LGBTQ+ individuals............ Survey Screener 1,125 1 2/60 38
Questionnaire.
General population............ Community Web- 4050 1 30/60 2025
Panel Survey.
Individuals in racial and Community Web- 600 1 30/60 300
ethnic groups. Panel Survey.
LGBTQ+ individuals............ Community Web- 450 1 30/60 225
Panel Survey.
General population............ Focus Group 34 1 3/60 2
Screener
Questionnaire.
Individuals in racial and Focus Group 33 1 3/60 2
ethnic groups. Screener
Questionnaire.
LGBTQ+ individuals............ Focus Group 33 1 3/60 2
Screener
Questionnaire.
General population............ Community Focus 25 1 60/60 25
Group.
Individuals in racial and Community Focus 25 1 60/60 25
ethnic groups. Group.
LGBTQ+ individuals............ Community Focus 25 1 60/60 25
Group.
Total..................... ................ .............. .............. .............. 3047
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-19613 Filed 8-30-24; 8:45 am]
BILLING CODE 4163-18-P